We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
CAT No: CP14604
CAS No: 41153-30-4
Synonyms/Alias: 41153-30-4;Boc-L-4-Fluorophenylalanine;Boc-Phe(4-F)-OH;Boc-4-fluoro-L-phenylalanine;N-(tert-Butoxycarbonyl)-4-fluoro-L-phenylalanine;boc-l-4-fluorophe;(s)-n-boc-4-fluorophenylalanine;(S)-2-((tert-butoxycarbonyl)amino)-3-(4-fluorophenyl)propanoic acid;boc-4-fluoro-phe-oh;(2S)-3-(4-fluorophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid;MFCD00079672;DTXSID60427310;Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-4-fluoro-;N-Boc-4-fluoro-L-phenylalanine;boc-p-fluoro-l-phenylalanine;SCHEMBL479232;N-Boc-(p-fluorophenylalanine);BOC-P-FLUORO-L-PHE-OH;N-Boc-(4-flouro)phenylalanine;CHEMBL5305290;DTXCID90378144;RCXSXRAUMLKRRL-NSHDSACASA-N;(2s)-2-[(tert-butoxycarbonyl)amino]-3-(4-fluorophenyl)propanoic acid;Nalpha -Boc-(p-fluoro) phenylalanine;(2S)-2-{[(tert-butoxy)carbonyl]amino}-3-(4-fluorophenyl)propanoic acid;AKOS015889957;Boc-3-(4-fluorophenyl)-(S)-alanine;AC-9901;CS-W012253;HY-W011537;DS-15151;PD196816;B3304;Boc-Phe(4-F)-OH, >=99.0% (TLC);EN300-317067;N10785;(S)-BOC-2-AMINO-3-(4-FLUOROPHENYL)PROPIONIC ACID;2(S)-tert-butoxycarbonylamino-3-(4-fluorophenyl)propionic acid;(s)-2-(tert-butoxycarbonylamino)-3-(4-fluorophenyl)propanoic acid;N-alpha-t-Butyloxycarbonyl-L-4-fluorophenylalanine (Boc-L-Phe(4-F)-OH);
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C14H18FNO4 |
M.W/Mr. | 283.29 |
Sequence | Three Letter Code:Boc-Phe(4-F)-OH |
Abbr | Boc-L-Phe(4-F) -OH |
InChI | InChI=1S/C14H18FNO4/c1-14(2,3)20-13(19)16-11(12(17)18)8-9-4-6-10(15)7-5-9/h4-7,11H,8H2,1-3H3,(H,16,19)(H,17,18)/t11-/m0/s1 |
InChI Key | RCXSXRAUMLKRRL-NSHDSACASA-N |
Canonical SMILES | CC(C)(C)OC(=O)NC(CC1=CC=C(C=C1)F)C(=O)O |
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
5. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com